1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Bhaskaran, R. Huang, C.C. Chang, K.D. Yu, C. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 269 23500 23508 8089116 Cardiotoxin II from Taiwan cobra venom, Naja naja atra. Structure in solution and comparison among homologous cardiotoxins. 1994 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 6760.242 CARDIOTOXIN II 1 man polymer no no LKCNKLVPLFYKTCPAGKNLCYKMFMVSNLTVPVKRGCIDVCPKNSALVKYVCCNTDRCN LKCNKLVPLFYKTCPAGKNLCYKMFMVSNLTVPVKRGCIDVCPKNSALVKYVCCNTDRCN A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Chinese cobra Naja sample 8656 Naja atra pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_conf repository Initial release Version format compliance Version format compliance Derived calculations Other 1 0 1994-05-31 1 1 2008-03-24 1 2 2011-07-13 1 3 2017-11-29 _pdbx_database_status.process_site Y BNL 1994-03-12 REL 12 BRUNGER refinement X-PLOR LEU 1 n 1 LEU 1 A LYS 2 n 2 LYS 2 A CYS 3 n 3 CYS 3 A ASN 4 n 4 ASN 4 A LYS 5 n 5 LYS 5 A LEU 6 n 6 LEU 6 A VAL 7 n 7 VAL 7 A PRO 8 n 8 PRO 8 A LEU 9 n 9 LEU 9 A PHE 10 n 10 PHE 10 A TYR 11 n 11 TYR 11 A LYS 12 n 12 LYS 12 A THR 13 n 13 THR 13 A CYS 14 n 14 CYS 14 A PRO 15 n 15 PRO 15 A ALA 16 n 16 ALA 16 A GLY 17 n 17 GLY 17 A LYS 18 n 18 LYS 18 A ASN 19 n 19 ASN 19 A LEU 20 n 20 LEU 20 A CYS 21 n 21 CYS 21 A TYR 22 n 22 TYR 22 A LYS 23 n 23 LYS 23 A MET 24 n 24 MET 24 A PHE 25 n 25 PHE 25 A MET 26 n 26 MET 26 A VAL 27 n 27 VAL 27 A SER 28 n 28 SER 28 A ASN 29 n 29 ASN 29 A LEU 30 n 30 LEU 30 A THR 31 n 31 THR 31 A VAL 32 n 32 VAL 32 A PRO 33 n 33 PRO 33 A VAL 34 n 34 VAL 34 A LYS 35 n 35 LYS 35 A ARG 36 n 36 ARG 36 A GLY 37 n 37 GLY 37 A CYS 38 n 38 CYS 38 A ILE 39 n 39 ILE 39 A ASP 40 n 40 ASP 40 A VAL 41 n 41 VAL 41 A CYS 42 n 42 CYS 42 A PRO 43 n 43 PRO 43 A LYS 44 n 44 LYS 44 A ASN 45 n 45 ASN 45 A SER 46 n 46 SER 46 A ALA 47 n 47 ALA 47 A LEU 48 n 48 LEU 48 A VAL 49 n 49 VAL 49 A LYS 50 n 50 LYS 50 A TYR 51 n 51 TYR 51 A VAL 52 n 52 VAL 52 A CYS 53 n 53 CYS 53 A CYS 54 n 54 CYS 54 A ASN 55 n 55 ASN 55 A THR 56 n 56 THR 56 A ASP 57 n 57 ASP 57 A ARG 58 n 58 ARG 58 A CYS 59 n 59 CYS 59 A ASN 60 n 60 ASN 60 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 1 A ARG 36 0.210 SIDE CHAIN 1 A ARG 58 0.240 SIDE CHAIN 2 A ARG 36 0.317 SIDE CHAIN 2 A ARG 58 0.263 SIDE CHAIN 3 A ARG 36 0.314 SIDE CHAIN 3 A ARG 58 0.314 SIDE CHAIN 4 A ARG 36 0.299 SIDE CHAIN 4 A ARG 58 0.252 SIDE CHAIN 5 A ARG 36 0.189 SIDE CHAIN 5 A ARG 58 0.282 SIDE CHAIN 6 A ARG 36 0.298 SIDE CHAIN 6 A ARG 58 0.241 SIDE CHAIN 7 A ARG 36 0.263 SIDE CHAIN 7 A ARG 58 0.286 SIDE CHAIN 8 A ARG 36 0.303 SIDE CHAIN 8 A ARG 58 0.307 SIDE CHAIN 9 A ARG 36 0.151 SIDE CHAIN 9 A ARG 58 0.273 SIDE CHAIN 10 A ARG 36 0.267 SIDE CHAIN 10 A ARG 58 0.247 SIDE CHAIN 11 A ARG 36 0.241 SIDE CHAIN 11 A ARG 58 0.177 SIDE CHAIN 12 A ARG 36 0.313 SIDE CHAIN 12 A ARG 58 0.198 SIDE CHAIN 1 A LEU 6 65.33 -93.23 1 A VAL 7 -172.41 -59.71 1 A PHE 10 58.81 177.15 1 A TYR 11 -137.73 -40.44 1 A LYS 12 93.56 -100.71 1 A ALA 16 59.83 135.21 1 A ASN 19 -147.85 -36.61 1 A SER 28 -128.59 -81.24 1 A LEU 30 -153.26 45.41 1 A THR 31 71.07 73.25 1 A ILE 39 -141.50 -151.06 1 A ASP 40 -135.11 -33.09 1 A CYS 42 -140.07 42.34 1 A LYS 44 72.41 164.05 1 A ASN 45 -155.49 -134.87 1 A SER 46 -169.07 -102.25 1 A ALA 47 -173.12 -38.88 1 A ASN 55 -98.59 -63.59 1 A ASP 57 65.00 120.68 1 A CYS 59 174.83 86.74 2 A LEU 6 61.13 166.97 2 A PRO 8 -82.17 42.32 2 A LEU 9 -178.24 -45.95 2 A PHE 10 65.99 -171.60 2 A TYR 11 -161.24 -94.12 2 A LYS 12 162.02 -68.16 2 A ALA 16 59.34 150.08 2 A LYS 18 62.44 146.06 2 A MET 24 -160.71 110.27 2 A PHE 25 -161.06 -165.36 2 A SER 28 -148.79 -46.09 2 A LEU 30 -160.19 67.24 2 A THR 31 76.10 102.78 2 A VAL 34 -143.84 -40.71 2 A ILE 39 -146.23 -148.41 2 A LYS 44 64.29 149.86 2 A SER 46 -106.92 -164.07 2 A ASN 55 -160.26 74.45 2 A THR 56 -160.81 78.68 2 A ASP 57 63.40 -87.95 3 A CYS 3 -110.80 -169.84 3 A LEU 6 62.45 -109.45 3 A VAL 7 -166.39 -61.53 3 A PHE 10 64.92 -179.83 3 A TYR 11 -137.29 -109.53 3 A LYS 12 175.82 -145.93 3 A ALA 16 63.54 139.66 3 A ASN 19 -154.12 -35.28 3 A PHE 25 -161.97 -159.86 3 A SER 28 -172.33 -69.85 3 A ASN 29 -88.43 -98.23 3 A LEU 30 -119.47 65.58 3 A THR 31 41.20 83.41 3 A VAL 34 -121.11 -83.59 3 A ILE 39 -160.75 -154.73 3 A LYS 44 65.49 146.24 3 A SER 46 -112.15 -150.46 3 A ALA 47 -131.93 -37.86 3 A ASN 55 -99.89 -82.18 3 A ASP 57 78.00 -76.09 3 A CYS 59 -162.93 114.53 4 A LEU 6 58.18 -172.85 4 A PHE 10 55.39 -175.87 4 A TYR 11 -153.19 -92.70 4 A LYS 12 157.72 -129.39 4 A ALA 16 -110.65 -157.91 4 A ASN 19 -132.26 -30.39 4 A SER 28 -157.88 -80.84 4 A ASN 29 -109.60 -83.27 4 A THR 31 63.25 66.01 4 A ILE 39 -138.15 -156.92 4 A LYS 44 155.22 162.64 4 A ASN 55 -154.80 63.18 4 A THR 56 -148.05 35.26 4 A ASP 57 77.42 -77.86 4 A ARG 58 -38.36 -30.32 4 A CYS 59 -143.93 59.09 5 A LEU 6 52.24 -96.97 5 A VAL 7 -153.19 -64.80 5 A LEU 9 83.94 -43.38 5 A PHE 10 65.78 -166.50 5 A TYR 11 -142.11 -108.52 5 A LYS 12 176.03 -138.04 5 A ALA 16 168.54 128.95 5 A LYS 18 -127.46 -138.49 5 A ASN 19 -156.54 -52.99 5 A LEU 20 -129.30 -169.97 5 A ASN 29 -132.92 -45.23 5 A LEU 30 -144.84 56.41 5 A THR 31 43.20 84.98 5 A VAL 34 -129.78 -61.17 5 A CYS 42 -162.79 107.14 5 A PRO 43 -79.60 -165.72 5 A ASN 45 -132.16 -64.65 5 A SER 46 80.93 -168.42 5 A ALA 47 85.38 -59.77 5 A LEU 48 -124.09 -50.67 5 A ASN 55 -99.55 -81.36 5 A ASP 57 179.72 -121.97 6 A CYS 3 -123.12 -164.84 6 A LEU 6 60.12 165.43 6 A PHE 10 59.31 173.91 6 A TYR 11 -148.17 -115.51 6 A LYS 12 172.47 -124.08 6 A ALA 16 59.45 150.04 6 A ASN 19 -133.62 -48.19 6 A SER 28 179.06 -54.11 6 A ASN 29 -120.10 -58.02 6 A LEU 30 -158.05 58.30 6 A THR 31 51.61 83.16 6 A VAL 34 -127.63 -51.38 6 A ILE 39 -144.11 -144.01 6 A ASP 40 -160.16 37.82 6 A PRO 43 -76.63 -160.67 6 A SER 46 -173.17 86.58 6 A ALA 47 -176.55 -72.96 6 A LEU 48 -154.38 22.08 6 A VAL 49 -154.02 85.35 6 A THR 56 -160.59 58.01 6 A ASP 57 66.53 149.75 6 A CYS 59 179.14 56.74 7 A LEU 6 54.86 171.75 7 A LEU 9 -132.36 -42.45 7 A PHE 10 62.45 175.35 7 A TYR 11 -154.01 -124.46 7 A LYS 12 -178.29 -72.34 7 A ALA 16 69.98 65.81 7 A SER 28 -165.87 -80.68 7 A ASN 29 -107.79 -91.42 7 A LEU 30 -114.42 56.39 7 A LYS 44 62.41 149.10 7 A SER 46 -132.32 -154.39 7 A THR 56 -157.06 32.85 7 A ASP 57 76.96 -79.18 8 A LEU 6 58.85 154.45 8 A LEU 9 -178.02 -53.09 8 A PHE 10 66.41 -164.40 8 A TYR 11 -157.40 -105.20 8 A LYS 12 -176.42 -77.53 8 A ALA 16 167.81 -166.42 8 A ASN 29 -121.80 -69.15 8 A THR 31 58.07 77.26 8 A VAL 34 -125.32 -69.90 8 A LYS 44 66.18 167.07 8 A SER 46 -111.25 -86.89 8 A ALA 47 161.56 -45.14 8 A ASN 55 -161.03 43.10 8 A THR 56 -145.77 56.36 8 A ASP 57 69.22 163.00 8 A ARG 58 48.00 22.38 8 A CYS 59 156.44 80.98 9 A LEU 6 67.00 -103.66 9 A VAL 7 -167.65 -60.16 9 A LEU 9 169.40 -32.62 9 A PHE 10 59.82 -170.36 9 A TYR 11 -135.00 -38.56 9 A LYS 12 103.89 -84.41 9 A LYS 18 -135.43 -73.82 9 A ASN 19 -160.24 -72.42 9 A PHE 25 -161.88 -166.25 9 A VAL 27 -46.85 166.18 9 A SER 28 -169.01 -66.47 9 A ASN 29 -142.49 -50.68 9 A LEU 30 -144.39 29.55 9 A THR 31 72.87 88.63 9 A VAL 34 -123.96 -55.66 9 A VAL 41 -157.43 74.38 9 A LYS 44 67.22 125.88 9 A ASN 45 -122.00 -144.40 9 A SER 46 -162.74 -30.31 9 A ALA 47 95.86 -27.15 9 A LYS 50 -34.01 115.53 9 A ASN 55 -153.84 54.07 9 A THR 56 -158.24 64.03 9 A ASP 57 54.61 165.72 9 A ARG 58 59.53 15.29 9 A CYS 59 159.55 68.46 10 A LEU 6 41.92 -99.31 10 A VAL 7 -176.17 -54.40 10 A PHE 10 71.86 -167.66 10 A TYR 11 -161.01 -121.91 10 A LYS 12 178.07 -102.85 10 A ALA 16 65.19 132.70 10 A PHE 25 -160.71 -168.94 10 A SER 28 -133.52 -76.25 10 A ASN 29 -104.85 -81.43 10 A THR 31 56.41 85.00 10 A VAL 34 -115.98 -76.00 10 A ILE 39 -149.10 -154.01 10 A VAL 41 -111.37 69.80 10 A LYS 44 73.35 117.06 10 A SER 46 -132.08 -73.54 10 A ALA 47 177.96 -29.09 10 A LEU 48 -99.50 -60.68 10 A ASN 55 -160.66 92.20 10 A THR 56 -151.04 -50.82 10 A ASP 57 167.95 -53.13 10 A CYS 59 -119.87 78.68 11 A LEU 6 176.26 -177.87 11 A PHE 10 62.52 178.72 11 A TYR 11 -150.48 -117.09 11 A LYS 12 -176.52 -88.32 11 A CYS 14 -150.55 65.86 11 A ALA 16 77.14 89.92 11 A PHE 25 -161.30 -169.35 11 A SER 28 -138.37 -55.94 11 A ASN 29 -158.50 -39.84 11 A LEU 30 -156.69 59.12 11 A THR 31 46.01 85.15 11 A ILE 39 -159.04 -131.21 11 A ASP 40 -156.96 23.14 11 A CYS 42 -140.87 47.88 11 A LYS 44 61.53 150.60 11 A LEU 48 -99.31 -67.16 11 A ASN 55 -161.25 56.33 11 A THR 56 -161.12 69.46 11 A ASP 57 56.17 162.67 11 A CYS 59 169.37 53.39 12 A CYS 3 -123.31 -167.13 12 A LEU 6 57.06 -169.73 12 A PHE 10 56.25 -169.72 12 A TYR 11 -153.88 -91.89 12 A LYS 12 160.49 -92.61 12 A ALA 16 59.42 118.98 12 A SER 28 -146.52 -68.32 12 A ASN 29 -114.09 -81.78 12 A LEU 30 -140.85 52.63 12 A THR 31 75.98 51.58 12 A SER 46 165.02 111.41 12 A ALA 47 156.98 -75.23 12 A ASN 55 -99.11 -78.80 12 A ASP 57 66.87 138.11 12 A CYS 59 161.77 93.71 model building X-PLOR refinement X-PLOR phasing X-PLOR CARDIOTOXIN II (NMR, 12 STRUCTURES) CARDIOTOXIN II FROM TAIWAN COBRA VENOM, NAJA NAJA ATRA: STRUCTURE IN SOLUTION AND COMPARISION AMONG HOMOLOGOUS CARDIOTOXINS 1 Y N disulf 2.020 A CYS 3 A SG CYS 3 1_555 A CYS 21 A SG CYS 21 1_555 disulf 2.023 A CYS 14 A SG CYS 14 1_555 A CYS 38 A SG CYS 38 1_555 disulf 2.017 A CYS 42 A SG CYS 42 1_555 A CYS 53 A SG CYS 53 1_555 disulf 2.018 A CYS 54 A SG CYS 54 1_555 A CYS 59 A SG CYS 59 1_555 CARDIOTOXIN CARDIOTOXIN CTX2_NAJAT UNP 1 1 P01442 MKTLLLTLVVVTIVCLDLGYTLKCNKLVPLFYKTCPAGKNLCYKMFMVSNLTVPVKRGCIDVCPKNSALVKYVCCNTDRC N 22 81 1CRF 1 60 P01442 A 1 1 60 2 3 anti-parallel anti-parallel anti-parallel A LYS 2 A LYS 2 A ASN 4 A ASN 4 A TYR 11 A TYR 11 A THR 13 A THR 13 A LEU 20 A LEU 20 A PHE 25 A PHE 25 A LYS 35 A LYS 35 A ILE 39 A ILE 39 A LYS 50 A LYS 50 A CYS 54 A CYS 54 1 P 1